首页 | 本学科首页   官方微博 | 高级检索  
     

间充质干细胞治疗激素耐药重度急性移植物抗宿主病
引用本文:翁建宇,杜欣,项鹏,陆泽生,吴穗晶,郭荣,罗成伟,凌伟,廖鹏军,邓程新,刘晓力. 间充质干细胞治疗激素耐药重度急性移植物抗宿主病[J]. 实用医学杂志, 2010, 26(1). DOI: 10.3969/j.issn.1006-5725.2010.01.037
作者姓名:翁建宇  杜欣  项鹏  陆泽生  吴穗晶  郭荣  罗成伟  凌伟  廖鹏军  邓程新  刘晓力
作者单位:1. 广东省人民医院血液科,广东省医学科学院,广州市,510080
2. 中山大学基因工程与干细胞中心,广州市,510080
3. 南方医科大学南方医院血液科,广州市,510515
摘    要:
目的:探讨体外扩增骨髓间充质干细胞(mesenchymal stem cells, MSCs)治疗激素耐药重度急性移植物抗宿主病(acute graft-versus-host disease, aGVHD)的临床疗效和安全性.方法:4例恶性血液病患者经HLA匹配同胞外周血干细胞联合骨髓移植后,诊断为激素耐药重度aGVHD,在原有免疫抑制治疗的基础上给予MSCs 0.5 × 106/kg受者体重.结果:4例患者经静脉输注体外扩增MSCs共9例次,未发现输注相关不良反应.所有患者均显示不同程度的治疗反应,总有效率达100%.4例发生消化道aGVHD,完全缓解2例,显著缓解1例,部分缓解1例.2例合并肝脏aGVHD患者中1例获完全缓解,1例获部分缓解.初始显效和充分显效的中位时间分别为3 d(2 ~ 5 d)和23 d(10 ~ 72 d).MSCs输注后,病情缓解者外周血CD8+CD28- T细胞比例明显上升,而CD8+CD28+ T细胞比例下降.结论:MSCs可快速缓解激素耐药重度aGVHD病情,其可能通过对CD8+CD28-/CD8+CD28+ T细胞比例的调控发挥抗aGVHD的作用.

关 键 词:移植物抗宿主病  激素  耐药  急性  间充质干细胞

Mesenchymal stem cells as salvage therapy for severe steroid-resistant acute graft-versus-host disease
WENG Jian-yu,DU Xin,XIANG Peng,LU Ze-sheng,WU Sui-jing,GUO Rong,LUO Cheng-wei,LING Wei,LIAO Peng-jun,DENG Cheng-xin,LIU Xiao-li. Mesenchymal stem cells as salvage therapy for severe steroid-resistant acute graft-versus-host disease[J]. The Journal of Practical Medicine, 2010, 26(1). DOI: 10.3969/j.issn.1006-5725.2010.01.037
Authors:WENG Jian-yu  DU Xin  XIANG Peng  LU Ze-sheng  WU Sui-jing  GUO Rong  LUO Cheng-wei  LING Wei  LIAO Peng-jun  DENG Cheng-xin  LIU Xiao-li
Affiliation:WENG Jian-yu,DU Xin,XIANG Peng,LU Ze-sheng,WU Sui-jing,GUO Rong,LUO Cheng-wei,LING Wei,LIAO Peng-jun,DENG Cheng-xin,LIU Xiao-li.Department of Haematology,Guangdong General Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China
Abstract:
Objective To explore the efficacy and safety of mesenchymal stem cells (MSCs) as a treatment for patients with severe steroid-resistant acute graft-versus-host disease (aGVHD). Methods Four patients,who received sibling peripheral blood stem cells and bone marrow transplantations,were diagnosed as severe steroid-resistant aGVHD based on the results of HLA experiment. On the basis of primary therapy with immunosuppressive agents (Cyclosporin A + Methotrexate,Methylprednisolone,Mycophenolate mofetil,Zenapax,e...
Keywords:Graft vs host disease  Steroid  Resistant  Acute  Mesenchymal stem cells  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号